AnalystsTrevor AllredTrevor Allred's Stock Forecasts
AnalystsTrevor Allred
Sectors:
Industries:
Analyst Ranking
Top 20%
#1040 out of 5290 analysts
Average Return
+44.29%
Win Rate
82%14 out of 17
Risk vs Reward
Poor
Good
Trevor Allred's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mbx Biosciences IncMBX | +141.75% | $12.43 | $30.05 | 2025-07-16 - 2026-06-03 | Buy |
Ligand Pharmaceuticals IncLGND | +111.92% | $104.48 | $221.41 | 2025-05-09 - 2026-05-08 | Buy |
Palvella Therapeutics IncPVLA | +103.53% | $56.71 | $115.42 | 2025-09-09 - 2026-06-03 | Buy |
Ligand Pharmaceuticals IncLGND | +73.33% | $135.23 | $234.40 | 2025-07-30 - 2026-06-03 | Buy |
Ligand Pharmaceuticals IncLGND | +62.24% | $122.23 | $198.31 | 2025-02-28 - 2026-02-27 | Buy |
Trevor Allred Analyst Color
Get additional color on Trevor Allred's coverage of popular stocks
Trevor Allred's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ligand Pharmaceuticals IncLGND | 8 | Buy | $277.00 | +18.17% | Maintains | 3 months ago |
Bridgebio Pharma IncBBIO | 2 | Buy | $81.00 | +23.70% | Maintains | 3 months ago |
Legend Biotech CorpLEGN | 1 | Buy | $75.00 | +108.45% | Initiates Coverage On | 5 months ago |
Design Therapeutics IncDSGN | 1 | Buy | $18.00 | +72.41% | Initiates Coverage On | 5 months ago |
Theravance Biopharma IncTBPH | 1 | Buy | $27.00 | +69.60% | Initiates Coverage On | 6 months ago |
Mbx Biosciences IncMBX | 2 | Buy | $80.00 | +166.22% | Maintains | 8 months ago |
Palvella Therapeutics IncPVLA | 1 | Buy | $85.00 | -26.36% | Initiates Coverage On | 9 months ago |
Innoviva IncINVA | 1 | Buy | $35.00 | +61.29% | Initiates Coverage On | 10 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.